For subscribers
Pfizer, Moderna race to roll out new boosters as Covid-19 becomes endemic
Sign up now: Get ST's newsletters delivered to your inbox
Moving forward, Pfizer and Moderna will roll out new booster shots and vaccines for younger age groups to support revenues.
PHOTO: REUTERS
Follow topic:
SINGAPORE - While US drugmakers like Pfizer and Moderna made a killing from Covid-19 mRNA vaccine sales last year, sustaining similar volumes this year will be a challenge as more parts of the world become fully vaccinated.
At their 2021 results briefings last month, both drugmakers said they expect Covid-19 to enter the endemic phase this year, but regular booster shots will be needed to protect the public from new infections.
